What is Reliefband Technologies?
Reliefband Technologies specializes in drug-free, non-drowsy wearable technology aimed at preventing and treating nausea and vomiting. Their FDA-cleared devices employ patented technology to safely stimulate the nervous system, offering relief from conditions such as motion sickness, morning sickness, and chemotherapy-induced nausea. The company's innovative products serve a broad demographic, including pregnant women, migraine sufferers, and individuals managing anxiety, with a strong emphasis on safety, efficacy, and rapid symptom management. Reliefband's technology has garnered trust from thousands of users and is recognized for its application in clinical settings.
How much funding has Reliefband Technologies raised?
Reliefband Technologies has raised a total of $7.8M across 3 funding rounds:
Private Equity
$1.8M
Private Equity
$5M
Debt
$1M
Private Equity (2015): $1.8M, investors not publicly disclosed
Private Equity (2015): $5M, investors not publicly disclosed
Debt (2017): $999K, investors not publicly disclosed
What's next for Reliefband Technologies?
The recent major strategic investment in Reliefband Technologies signals a pivotal phase for the company, likely focused on scaling operations, expanding market reach, and further research and development. This significant capital infusion, coupled with the company's established presence in the wearable health device market, positions Reliefband for accelerated growth. Future strategies may involve enhancing product lines, exploring new therapeutic applications for their patented technology, and strengthening distribution channels to capture a larger share of the global health and wellness market. The company's commitment to drug-free, non-drowsy solutions aligns with growing consumer demand for natural and safe health interventions.
See full Reliefband Technologies company page
